Intriguingly, the deletion and/or inhibition of PARP1 greatly reduces or prevents these pathologies in an Xrcc1-defective mouse model of SSB-associated neurological disease, highlighting excessive/aberrant PARP1 activity as a source of SSB-induced neuropathology18,19. Here, PARP1 is linked to nervous system disorder.